William D Hazelton

6PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 04, 2026
Modeled sojourn time and sensitivity for detecting preclinical cancers retrospectively by a multi-cancer early detection test.

|Jan 20, 2026
Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Metastatic Endometrial Cancer.

Dib Sassine, Yongmei Huang, Chin Hur

|Jul 01, 2025
Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States.

Jason D Wright, Matthew T Prest, Jennifer S Ferris

|Jun 12, 2025
Diverse modes of T cell receptor sequence convergence define unique functional and cellular phenotypes.

Stefan Schattgen, Kasi Vegesana, William D Hazelton

|May 03, 2021
Modeling historic incidence trends implies early field cancerization in esophageal squamous cell carcinoma.

Georg E Luebeck, Thomas L Vaughan, Kit Curtius

|Nov 08, 2019
Epigenetic Aging: More Than Just a Clock When It Comes to Cancer.

Ming Yu, William D Hazelton, Georg E Luebeck

Pageof 1

Frequent Collaborators

3 joint publications

Georg E Luebeck

2 joint publications

Chung Yin Kong

2 joint publications

Tracy M Layne

2 joint publications

Goli Samimi